Inhibitory effects of recombinant manganese superoxide dismutase on influenza virus infections in mice

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 11, 1996, Pages 2626-2631

  Sidwell, Robert W ^a   Huffman, John H ^a   Bailey, Kevin W ^a   Wong, Min Hui ^a   Nimrod, Abraham ^b   Panet, Amos ^b  

^a UTAH STATE UNIVERSITY   (United States)

^b Kiryat Weizmann   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL ENZYME; OXYGEN RADICAL; OXYTETRACYCLINE; PYRAN COPOLYMER; RECOMBINANT MANGANESE SUPEROXIDE DISMUTASE; RIBAVIRIN; SCAVENGER; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL OXYGEN SATURATION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MIXTURE; FEMALE; INFLAMMATION; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS B; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029861167     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.11.2626     Document Type: Article

References (23)

1. 2-generation by xanthine oxidase of pathogenesis of influenza virus infection in mice. J. Clin. Invest. 85:739-745.
2. Beck, V., D. Bartfeld, Z. Yavin, A. Levanon, M. Gorecki, and J. R. Hartman. 1988. Efficient production of active manganese superoxide dismutase in Escherichia coli. Biotechnology 6:930-935.
3. Blake, D. R., N. D. Hall, P. A. Bacon, P. A. Dieppe, B. Halliwell, and J. M. C. Gutterridge. 1983. Effect of a specific iron chelating agent on animal models of inflammation. Ann. Rheum. Dis. 42:89-93.
4. Gilbert, B. E., P. R. Wyde, M. W. Ambrose, S. Z. Wilson, and V. Knight. 1992. Further studies with short duration ribavirin aerosol for the treatment of influenza virus infections in mice and respiratory syncytial virus infection in cotton rats. Antivir. Res. 17:33-42.
5. Gorecki, M., Y. Beck, J. R. Hartman, M. Fischer, L. Weiss, Z. Tochner, S. Slavin, and A. Nimrod. 1991. Recombinant human superoxide dismutases: production and potential therapeutical uses. Free Radical Res. Comms. 12-13:401-410.
6. Hers, J. F. P., J. Mulder, N. Masurel, L. V. D. Kuip, and D. A. J. Tyrrell. 1962. Studies on the pathogenesis of influenza virus pneumonia in mice. J. Pathol. Bacteriol. 83:707-717.
7. Hoffman, C. E. 1973. Amantadine HCl and related compounds, p. 199-212. In W. A. Carter (ed.), Selective inhibitors of viral functions. CRC Press, Boca Raton, Fla.
8. Loosli, C. G., R. D. Buckly, J. D. Hardy, M. S. Hertweck, S. H. Kow, R. Serebrin, D. P. Ryan, and S. F. Stinson. 1971. The pathogenesis of postinfluenzal collapse of the lungs of mice. Trans. Assoc. Am. Physicians 84:182-189.
9. Maeda, H., and T. Akaike. 1991. Oxygen free radicals as pathogenic molecules in viral diseases. Proc. Soc. Exp. Biol. Med. 198:721-727.
10. McManus, N. H. 1976. Microtiter assay for infection: microspectrophotometric quantitation of cytopathic effect. Appl. Environ. Microbiol. 31:35-38.
11. Nimrod, A., Y. Beck, J. R. Hartman, and M. Gorecki. 1989. Recombinant human manganese superoxide dismutase (r-hMnSOD) is a potent anti-inflammatory agent, p. 743-746. In O. Hayaishi, E. Niki, M. Kondo, and T. Yoshikawa (ed.), Medical, biochemical and chemical aspects of free radicals. Elsevier Science Publishers, Amsterdam.
12. Nimrod, A., N. Ezov, B. Parizada, L. Weiss, Z. Tochner, S. Slavin, A. Panet, and M. Gorecki. 1994. Human recombinant CuZnSOD and MnSOD as potential therapeutic agents, p. 383-387. In K. Asada and T. Yoshikawa (ed.), Frontiers of reactive oxygen species in biology and medicine. Elsevier Science Publishers, Amsterdam.
13. Oda, T., T. Akaike, T. Hamato, F. Suzuki, T. Hirano, and H. Maeda. 1989. Oxygen radicals in influenza-induced pathogenesis and treatment with pyran polymer-conjugated SOD. Science 244:974-976.
14. Prichard, M. N., and C. Shipman, Jr. 1990. A three-dimensional model to analyze drug-drug interactions. Antivir. Res. 14:181-206.
15. Raut, S., J. Hurd, R. J. Cureton, G. Blandford, and R. B. Heath. 1975. The pathogenesis of infections of the mouse caused by virulent and avirulent variations of an influenza virus. J. Med. Microbiol. 8:127-136.
16. Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty percent end points. Am. J. Hyg. 27:493-497.
17. Sidwell, R. W., K. W. Bailey, M. H. Wong, and J. H. Huffman. 1995. In vitro and in vivo susceptibility of a non-mouse-adapted influenza A (Beijing) virus infection to amantadine and ribavirin. Chemotherapy 41:455-461.
18. Sidwell, R. W., and J. H. Huffman. 1971. Use of disposable micro tissue culture plates for antiviral and interferon induction studies. Appl. Microbiol. 22:797-801.
19. Sidwell, R. W., J. H. Huffman, E. W. Call, H. Alaghamandan, P. D. Cook, and R. K. Robins. 1986. Effect of selenazofurin on influenza A and B virus infections of mice. Antivir. Res. 6:343-353.
20. Sidwell, R. W., J. H. Huffman, J. Gilbert, B. Moscon, G. Pedersen, R. Burger, and R. P. Warren. 1992. Utilization of pulse oximetry for the study of the inhibitory effects of antiviral agents on influenza virus in mice. Antimicrob. Agents Chemother. 36:473-476.
21. Sidirell, H. W., J. H. Huffman, B. J. Moscon, and R. P. Warren. 1994. Influenza virus-inhibitory effects of intraperitoneally and aerosol-administered SP-303, a plant flavonoid. Chemotherapy 40:42-50.
22. Tate, R. M., and J. E. Repine. 1983. Neutrophils and the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 128:552-559.
23. Wyde, P. R., R. B. Couch, B. F. Mackler, T. R. Cate, and B. M. Levy. 1977. Effects of low- and high-passage influenza virus infection in normal and nude mice. Infect. Immun. 15:221-229.